ALSA Ventures — Pre-Seed & Seed VC Firm
ALSA Ventures is a Pre-Seed, Seed venture capital firm based in London, England investing in Healthcare, Other. The firm has 8 portfolio companies in our records.
- Portfolio
- 8 companies on record
- Partners
- 4 listed
- AUM
- $500M
- Stage
- Pre-Seed, Seed
- Sectors
- Healthcare, Other
- HQ
- London, England
- Check size
- Not in our records
Pre-Seed, Seed
$500M
8+ companies
4 partners
Investment Thesis
Biotechnology investor focused on novel therapeutics across the drug development spectrum. Though international, it can be relevant for US companies with global syndication potential.
How ALSA Ventures invests
ALSA Ventures is a vc firm based in London, England. The firm invests at the Pre-Seed, Seed stages, with a focus on Healthcare, Other.
ALSA Ventures manages approximately $500M in assets. Our records include 1 fund raised by the firm.
ALSA Ventures has backed 8 companies in our records, including ReproNovo, Axovia Therapeutics, Vantage Biosciences.
Partners & Team
Industry Focus
Invests In
Funds
Fund III
Portfolio Companies (8)
Other
ReproNovo
Developing a pipeline of innovative treatments to address critical gaps in reproductive medicine and women’s health
Axovia Therapeutics
Axovia Therapeutics is developing the first gene therapy to treat diseases caused by cilia dysfunction.
Vantage Biosciences
Vantage Biosciences is an ALSA Ventures company at the forefront of targeting the root cause of vision loss associated with diabetes.
Promatix
Promatix is an ALSA Group company using multi-omic insights to develop the next generation of cancer therapeutics.
Montis Biosciences
Treating chronic inflammatory diseases by modulating the immune status of the perivascular milieu.
Epsilogen
World leader in IgE drugs with a pipeline of therapies to treat solid cancer tumours.
Oxford BioTherapeutics
Pipeline of first in class oncology drugs leveraging a proprietary database.
Eccocar
A European tech company; the specific business focus was not visible in the gathered snippet
- •Raising at Pre-Seed, Seed? You're squarely in their sweet spot.
- •Lead with your fit in Healthcare, Other — the sectors they actively back.
- •warm intro preferred
- •Address your outreach to a specific partner, such as Alek Safarian, Chief Executive Officer.
- •A warm introduction beats a cold email. Get matched and request an intro.
Featured In
Browse More Investors
Fundraising resources
Frequently Asked Questions
See if ALSA Ventures is a match for your startup
Upload your pitch deck to see how well you match with ALSA Ventures and 10,000+ other investors.
Ask your AI assistant about this investor: connect InvestorMatch to Claude or ChatGPT
Is this your profile? Request a correction or removal